Pfizer's Decision to Develop mRNA Vaccines on Its Own: Brilliant or Boneheaded?
Pfizer (NYSE: PFE) worked with its German partner BioNTech (NASDAQ: BNTX) to develop and launch the world's first COVID-19 vaccine. But now the big drugmaker says that it plans to develop future messenger RNA (mRNA) vaccines on its own. In this Motley Fool Live video recorded on March 24, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not this is a smart strategy for Pfizer.
Source Fool.com